Unveiling the Link Between Macular Microaneurysms and Chronic Kidney Disease in Diabetic Retinopathy
A groundbreaking study has uncovered a significant correlation between chronic kidney disease (CKD) and the presence of deep capillary plexus microaneurysms (MA) in patients with diabetic retinopathy. This research introduces the potential of MA count as a novel marker for systemic microvascular disease, particularly in those with referable diabetic retinopathy (refDR).
The study's lead investigator, Amani Fawzi, MD, from Northwestern University's Feinberg School of Medicine, and her colleagues emphasize the importance of this finding. They suggest that a higher MA burden could indicate deep capillary plexus (DCP) ischemia and be linked to extraocular vascular comorbidities in high-risk patients with refDR. This insight could revolutionize the way we assess microvascular health, allowing for earlier interventions and improved collaboration between ophthalmologists and primary care providers.
Optical coherence tomography angiography (OCTA), a noninvasive imaging technique, plays a crucial role in this study. It provides detailed quantitative perfusion metrics within the DCP, which is associated with visual decline and DR complications. The research team explored the relationship between OCTA-derived macular perfusion metrics, MA counts, and CKD, filling a gap in the existing literature.
Fawzi and her team conducted a cross-sectional study involving 65 patients with refDR and CKD, defined by an eGFR consistently below 60 mL/min/1.73 m² for at least three months. They utilized OCTA to capture multiple fovea-centered 3 × 3-mm scans, analyzing various parameters to assess the utility of MA count as a screening tool for systemic vascular comorbidities.
The analysis revealed that increased MA count was significantly associated with CKD, nonperfusion index (NPI), and specific OCTA metrics: vessel length density in the DCP (VLD-DCP), geometric perfusion deficits in the superficial capillary plexus (GPD-SCP), and GPD in the DCP. These findings were confirmed through multivariable modeling, where CKD remained a significant independent predictor of higher MA count.
Furthermore, the study's receiver operating characteristic (ROC) analysis demonstrated the discriminative ability of MA count in identifying CKD. A threshold of 14 macular MAs maximized the Youden index, achieving a sensitivity of 58.8% and a specificity of 86.4% for CKD detection. This highlights the potential of MA count as a valuable biomarker for both localized and systemic microvascular health.
In conclusion, this research highlights the significance of macular MAs as a cross-disciplinary biomarker, linking DCP ischemia and systemic microvascular injury associated with CKD. By combining OCTA with ultra-widefield fluorescein angiography, the study showcases the potential for MA count to stratify systemic risk within a high-risk diabetic retinopathy cohort.
Further exploration of this biomarker could lead to improved patient management and a deeper understanding of the intricate relationship between diabetic retinopathy and CKD.
